Our Ideas - Pharma

These are the posts from the Our Ideas section that have been tagged with Pharma.

To see all tags used in our posts, click here.

US Capitol dome

21st Century Cures Act: a commercial perspective on how the new FDA regulation could revolutionise use of RWE and analytics in healthcare

David Cooney | 15th June 2017

The 21st Century Cures Act was signed into law last December during the Obama administration. It brings numerous changes to the US drug development landscape, impacting patients, academia, research institutions, and industry. Over the last number of months Blue Latitude have been engaging with US pharma companies to help our clients understand its implications and how it could be leveraged.

read more

Culture cannot be global - Blue Latitude Health

Culture cannot be global: doing business outside your comfort zone

Dorottya Okros | 12th April 2017

Cultural context is everything when you’re working with teams from a different background to your own. Senior Associate UX Researcher Dorottya Okros talks through the common communication and negotiation pitfalls of working with Eastern Europe and the CIS for British presenters.

read more

channeling-your-inner-disruptor-kid-screaming-microphone

Channelling your inner disruptor

Jenna Earl | 5th April 2017

Channel strategy has long been a hot topic for pharma and is often regarded as the answer to many of today’s marketing challenges. Head of Brand Strategy Jenna Earl discusses these challenges faced by pharmaceutical marketers today, and if channel disruption is really the answer.

read more

Black and white - elderly man - face - Blue Latitude Health

Caring for prostate cancer patients

Frances Peters | 15th March 2017

Although not without its challenges, the appropriate care and support available to patients with prostate cancer is gradually evolving. Associate Consultant Frances Peters takes a look at the issues and concerns facing the caregivers of those with prostate cancer. 

read more

intro-to-manufacturing-biologics-lab-science

Introduction to the manufacturing of biologics

Ditte Funding | 12th December 2016

The last decade has seen the rapid growth of biologics in the pharma market, making them a key sector to watch. With their growing popularity, it’s important to understand the opportunities and threats they present. Associate Consultant Ditte Funding takes us through how biologics are made, what makes them unique, and what it all means for pharma companies.

read more

patient-perspective-living-with-crohns-disease-blue-latitude-health

Living with Crohn's disease: a patient perspective

Victoria Morton | 16th November 2016

Account Executive Victoria Morton explores what it’s like to live with Crohn’s disease as a young person, and investigates what’s being done to tackle the gaps in treatment options for patients.

read more

compass-hand-sea-navigation-guidance-photograph

Are reverse auctions the best way to procure marketing services?

Martin Brass | 6th October 2016

Managing Director Martin Brass discusses what a reverse auction is, and whether it truly is a good way for healthcare companies to drive efficiencies when procuring marketing services.

read more

photo-sad-man-powder-face

Are we harnessing the full emotional power of brand creativity?

Damien Parsonage | 30th September 2016

Creative Director Damien Parsonage breaks down the common misconception that pharma and healthcare marketing for healthcare professionals ought to be entirely scientific and rational. Brands are powerful; here's how to strengthen yours by infusing it with emotion.

read more

chessboard-strategy-photo

Marketing strategy in complex environments

Mark Assenti, Kulveer Singh | 19th September 2016

Age-old treatment protocols are being replaced with new and innovative treatment paradigms that will revolutionise the healthcare industry for years to come. Kulveer Singh and Mark Assenti talk through what this means for pharma strategists and their product lines.

read more

library-card-file-stock-photograph_DAM-vs-CMS-pharma-content-management

DAM and CMS: managing assets to maximise adoption and value

David Wood | 14th September 2016

Senior Account Executive Dave Wood talks us through what DAM and CMS are, the role they play in the future of healthcare marketing, and how they can be best utilised to maximise outcomes for pharma and agencies.

read more